Home/Filings/4/0001610717-23-000225
4//SEC Filing

Stone Paul A. 4

Accession 0001610717-23-000225

CIK 0001676725other

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 7:21 PM ET

Size

5.1 KB

Accession

0001610717-23-000225

Insider Transaction Report

Form 4
Period: 2023-08-09
Stone Paul A.
SVP, General Counsel
Transactions
  • Sale

    Common Stock

    2023-08-09$25.05/sh2,500$62,61319,303 total
Footnotes (2)
  • [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 27, 2023.
  • [F2]This transaction was executed in multiple trades in prices ranging from $25.00 to $25.105, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Documents

1 file

Issuer

IDEAYA Biosciences, Inc.

CIK 0001676725

Entity typeother

Related Parties

1
  • filerCIK 0001777511

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 7:21 PM ET
Size
5.1 KB